We have recently described the existence of a chaperone activity for the dimeric peptidyl-prolyl cis/trans isomerase FkpA from the periplasm of Escherichia coli that is independent of its isomerase activity. We have now investigated the molecular mechansim of these two activities in vitro in greater detail. The isomerase activity with a protein substrate (RNaseT1) is characterized by a 100-fold higher k cat /K M value than with a short tetrapeptide substrate. This enhanced activity with a protein is due to an increased af®nity towards the protein substrate mediated by a polypeptide-binding site that is distinct from the active site. The chaperone activity is also mediated by interaction of folding and unfolding intermediates with a binding site that is most likely identical to the polypeptide-binding site which enhances catalysis. Both activities are thus mechanistically related, being based on the transient interaction with this high-af®nity polypeptide-binding site. Only the isomerase activity, but not the chaperone activity, with the substrate citrate synthase can be inhibited by FK520. Experiments with the isolated domains of FkpA imply that both the isomerase and the chaperone site are located on the highly conserved FKBP domain. The additional amino-terminal domain mediates the dimerization and thus places the two active sites of the FKBP domains in juxtaposition, such that they can simultaneously interact with a protein, and this is required for full catalytic activity.
Introduction
Folding in the cell has usually been thought to be assisted by two separate classes of proteins. On the one hand different kinds of molecular chaperones have been discovered that act by preventing off-pathway reactions, which would otherwise lead to aggregation. 1 On the other hand, so-called`f olding catalysts'' have been described that catalyze rate-limiting steps in protein folding. Besides the formation and isomerization of disul®de bonds, 2 the major chemical rate-limiting step in protein folding is the cis/trans isomerization of peptidyl-bonds N-terminal to proline. Enzymes which catalyze this prolyl isomerization occur in all forms of life, from primates to archaea. 3 ± 5 They were found to belong to three families, named cyclophilins (Cyp), FK506-binding proteins (FKBPs), and parvulins. Because of their inhibition by immunosuppressant drugs (cyclosporin A or FK506), the ®rst two families are also called immunophilins. Despite their ubiquitous occurrence, however, most of these enzymes are not essential under normal growth conditions. In yeast, for example, 12 peptidyl-prolyl-cis/trans isomerases (PPIases) have been knocked out with only a subtle effect on the phenotype, 6 implying that they can be functionally replaced by other proteins.
In vitro, the PPIases have initially been characterized by their ability to catalyze peptide bond rotation in a short tetrapeptide model substrate. 7, 8 As judged by this assay, their activities differ widely, with second-order rate constants k cat /K M ranging from 10 3 M À1 s À1 up to almost the diffusion limit.
The FKBPs are a family of PPIases that have been named due to their ability to bind the inhibitor FK506, a macrolide isolated from Streptomyces tsukubaensis. 9 This inhibitor was initially discovered for its immunosupressive effect, and since then several analogs have been isolated from different Streptomyces strains. FK520, the analogue used in this study, was isolated from Streptomyces hygroscopicus. 10, 11 It differs from FK506 only by one propenyl moiety that is replaced by an ethyl group in a position which does not interact with FKBPs. Their potential role as a target for immunosuppressants is also the main reason for the sustained interest in this class of proteins (for a review, see Fruman et al. 12 ). FkpA was originally discovered as a periplasmic Escherichia coli homolog of the MIP-like FK506-binding proteins. 13 The macrophage infectivity potentiators (MIP), in turn, have been described in Legionella species to facilitate the invasion of the host cells by these intracellular parasites, and were found to be dimeric FKBPs with an additional N-terminal domain. 14 FkpA also consists of a highly conserved FKBP-domain, which is about 50 % identical to this domain in members of the MIP-family and an additional N-terminal domain, which is homologous to the respective domain of the MIP-proteins and some other two-domain FKBPs. A largely helical structure has been predicted for this N-terminal domain, its function, however, remained unknown. Recently, we have shown that FkpA, a dimer under native conditions, is a very ef®cient proline cis/trans isomerization catalyst with a folding protein as substrate and that it possesses an independent chaperonelike activity, 15 similar to other members of the FKBP-family. 16, 17 We have now investigated the molecular mechanism of these apparently separate activities of FkpA in detail, to gain a better understanding of its function in vivo.
Results
High isomerase activity with protein substrates mediated by tight substrate binding Recently, we described the high PPIase activity of FkpA with protein substrates. This was demonstrated in a protein folding assay measuring the catalysis of wild-type (wt) RNaseT1 refolding. 15 A 13-fold acceleration of the prolyl isomerization-limited folding rate was observed in the presence of 10 nM FkpA, whereas the homologous human FKBP12, used as reference, showed no effect at this concentration ( Figure 1(a) ). The k cat /K M value of 4 Â 10 6 M À1 s
À1
, determined for the FkpA dimer, was much higher than the one which had been estimated before 18 for FkpA from a protease- Figure 1 . (a) Fluorescence traces of RNaseT1 refolding (0.4 mM) at 10 C, starting from equilibrium-denatured protein and in the presence of 10 nM FkpA or 10 nM human FKBP12, as indicated. The intensity was followed at 323 nm upon excitation at 295 nm. (b) Catalysis of the isomerization of a tetrapeptide (Suc-Ala-AlaPro-Phe-NA). Kinetic traces were evaluated with a single exponential, and the ratios of the rates of catalyzed isomerization, divided by the uncatalyzed rate, are plotted against the respective FkpA concentration present during the measurement. From the slope of the line a value of 5 Â 10 4 M À1 s À1 can be estimated for
coupled colorimetric assay with a peptide substrate (9 Â 10 4 M À1 s
). Since we observed rapid degradation of FkpA in the presence of the chymotrypsin concentrations employed in the protease-coupled peptide assay, implying that rapid digestion within the assay might be the reason for the low catalytic activity, we have now reexamined the isomerase activity of FkpA with a tetrapeptide using a photometric assay that can be carried out in the absence of any protease. 19 From the slope of the plot shown in Figure 1( ). It is thus clear that FkpA has indeed a rather low k cat /K M value with a tetrapeptide as substrate, 17-fold lower than the homologous hFKBP12, and that this is not an artefact of its own susceptibility to the protease. This stands in marked contrast to its almost 100-fold higher catalytic activity with a folding protein, which hFKBP12 in turn catalyzes very inef®ciently.
To understand the basis of this enhanced catalytic activity with a folding protein, compared to a short tetrapeptide, we determined the kinetic parameters K M and k cat of the catalysis of FkpA with RNaseT1 wt and a mutant. In these experiments the concentration of FkpA was kept constant at 10 nM, and the substrate RNaseT1 concentration was varied between 0.05 and 2 mM (wt) or 0.05 and 6 mM (mutant), while care was taken to ensure identical ®nal refolding conditions. Since uncatalyzed refolding occurs in parallel with the catalyzed reaction, the amplitude of the uncatalyzed reaction dominates the observed kinetics at high substrate concentrations, thus complicating the analysis. The measured kinetic traces were, therefore, analyzed by numerical iteration and global ®t to the progress curves with the program DynaFit, 21 based on a model that accounts for the presence of the uncatalyzed reaction (see Experimental Procedures), whose rate had been determined independently and was held constant in the ®tting procedure.
Since the refolding kinetics of the wt RNaseT1 are very complex, with three different proline-limited reactions all contributing to the faster phase observed in¯uorescence measurements 22, 23 and an additional slow proline-limited phase, the determination of single K M and k cat values is not possible, strictly speaking. The isomerization reactions in RNaseT1 wt can be catalyzed to different extents, however, and isomerases also affect which branch of the folding pathway the slow-folding molecules choose, resulting in dramatic changes in the amplitudes of the different slow refolding reactions. 23 Since only the faster phase of proline-limited RNaseT1 wt-folding is catalyzed well by FkpA (Figure 2(a) ), while the amplitude of the slower phase decreases dramatically, we believe that the values determined from analysis of the faster phase are still provide a good estimate for the catalytic constants of FkpA, albeit averaged for a small Chaperone and Isomerase Activity of FkpA number of structurally closely related RNaseT1 wt folding intermediates as substrates. A mathematically correct analysis of the data is, on the other hand, possible with a mutant of RNaseT1 as substrate, which lacks one of the two cis-prolines (P55N) and is additionally reduced and carboxymethylated to prevent disul®de-bond formation (RCM-RNaseT1). Its folding mechanism is simple and well characterized 24, 25 and it has been used as a model substrate for PPIases before. 16, 26 The tradeoff for this substrate is, however, that it requires 2 M NaCl for stability and that the experimental conditions are, therefore, not physiological, and it appears that product dissociation becomes rate limiting (see below). We therefore measured the effect of FkpA on the folding of both wt RNaseT1 and RCM-RNaseT1.
The analysis of the data obtained for the wt RNaseT1 yields values of 0.5 mM for K M and 1.6 s À1 for k cat (data not shown). It is interesting to note that the catalysis of the RCM-RNaseT1 is not more ef®cient than that of the wt RNaseT1, even though substrate binding is apparently even stronger. RCM-RNaseT1 is known to form no stable structured folding intermediates in contrast to the wt protein, 28 and this may be the reason for the tighter binding to FkpA. The lower k cat value may indicate that release of the substrate rather than bond rotation has become rate-limiting. The FKB-proteins owe their name to the fact that they bind the inhibitor FK506 more or less tightly in the active site. FK520 is essentially identical with FK506, 9 differing only by possessing an ethyl group that does not participate in the interaction 29 instead of a propenyl group in FK506. To determine the binding constant of FkpA to FK520 11 we performed inhibition measurements with the wt RNaseT1 as a substrate. Catalysis of RNaseT1 wt refolding at 10 C (Figure 3(a) ) is fully inhibited with 100 nM FK520 and the ®t yields a K i value of 10 nM. Binding of the inhibitor is not disturbed by an increase of the assay temperature up to 25 C. Measurements at even higher temperatures are, however, not possible with this folding assay. The K i obtained is in good agreement with the K i of about 30 nM for FK506, which has been reported very recently for FkpA based on a tetrapeptide assay. 27 Figure 3. Inhibition of the catalytic activity with wt RNaseT1 as substrate at 10 C by FK520 (10 nM FkpA dimer). Kinetic traces were analyzed by double exponential ®ts. The obtained rates for the faster reaction were divided by the uncatalyzed rate and plotted. The ®t yields a K i value of 10 nM. (b) Fluorescence titration of FkpA (1 mM, dimer) with FK520 at (*) 25 C and (*) 38 C, followed at 307 nm upon excitation at 280 nm. The ®t yields an active site concentration of about 1.6 mM, but since the FkpA concentration is much higher than K D in this experiment, K D cannot be determined.
We have shown before that FkpA is exclusively dimeric under all conditions tested in solution, 15 such that there are two active sites per native dimer. In order to con®rm that both active sites on the dimer are accessible to the inhibitor, we carried out¯uorescence titration experiments ( Figure 3(b) ). The titrations were performed at 25 C as well as at 38 C, to establish whether inhibitor binding also occurs at the elevated temperatures used in chaperone experiments (see below). When 1 mM dimeric FkpA, a much higher concentration than the K i determined from kinetic inhibition, is titrated with FK520, the stoichiometry of binding can be determined. An active site concentration of about 1.6 mM is obtained at both temperatures (®t in Figure 3 (b)). The somewhat reduced concentration of active sites compared to the expected number of 2 mM probably arises from the prolonged pre-incubation in the cuvette, which is necessary to prevent titration artefacts due to¯uorescence decrease caused by some absorption to the cuvette. Importantly, the results clearly show that binding of the inhibitor to the catalytic site occurs at all temperatures from 10 C to 38 C.
RCM a a a-lactalbumin competes for protein substrate binding only
In order to determine whether the low K M value for RNaseT1 is due to an avidity effect of binding to both active sites on the FkpA dimer, or rather mediated by binding to a site distinct from the active site, we performed inhibition studies with reduced and carboxymethylated bovine a-lactalbumin (RCM-la). RCM-la is denatured and unfolded under physiological conditions and, most importantly, it remains soluble and unfolded under the conditions used in the assay. RCM-la has been shown before to be a substrate for GroEL 30 and to compete with RNaseT1 for binding to the trigger factor. 26 RCM-la inhibits the catalysis of RNaseT1 refolding at micromolar concentrations ( Figure 4(a) ). The inhibition follows a saturation curve, and the measured rate of refolding of RNaseT1 in the presence of high inhibitor concentrations approaches the rate of uncatalyzed refolding. Inhibition is, however, never complete and this might be due to the fact that the inhibitor blocks only the additional polypeptide-binding site, thus increasing the K M , but not the catalytic site itself. Half-maximal inhibition was observed at 3 mM RCM-la. The catalysis of the isomerization of the tetrapeptide, on the other hand, is not inhibited at all, even in the presence of 170 mM RCM-la, a 850-fold excess over FkpA (Figure 4(b) ). These results suggest that RCM-la does not block the active sites of FkpA, since the catalysis of the tetrapeptide is not in¯uenced. The inhibitory effect on the catalysis of the folding protein must thus be explained by a competition of RCM-la with RNaseT1 for binding. Since the actual catalysis of the tetrapeptide substrate is undisturbed, the binding of RCM-la must occur to a site on FkpA that is distinct from the active site, but can of course be adjacent to it.
It is tempting to speculate that the additional binding capacity for polypeptides may also be the basis for the chaperone activity of FkpA that has been shown to exist independently of its isomerase activity. 15, 31 In order to investigate this hypothesis and to gain a better understanding of the mode of polypeptide binding, we carried out experiments with a chaperone model substrate that is well characterized and allows testing for chaperone activity in the presence of the active site inhibitor FK520.
FkpA prevents aggregation of unfolding CS intermediates
Experiments addressing the chaperone activity in the presence of the active site inhibitor FK520 could not be carried out with the substrate used before, a single-chain fragment of an antibody, 15 due to severe aggregation of the scFv in the refolding reaction caused by the presence of the inhibitor FK520 alone, a large hydrophobic macrolide. This may be a general problem when probing chaperone activity with refolding proteins in the presence of FK506-derivatives. We have therefore chosen to investigate the chaperone activity of FkpA further, making use of a well-described chaperone substrate, citrate synthase (CS). Native CS is known to lose activity and subsequently aggregate upon incubation at elevated temperatures. 32 In the course of thermal unfolding, two native-like intermediates are populated transiently that can be reactivated by the addition of oxaloacetate (OAA). The action of different families of chaperones on CS unfolding has been described in considerable detail. 17, 33 Upon coincubation with CS at 43 C, FkpA is able to delay and reduce light scattering. At an eightfold molar excess of FkpA (0.6 mM) over CS, no visible aggregation, detectable by light scattering, occurs over the time of the experiment ( Figure 5(a) ). Bovine serum albumin (BSA) at the same concentration does not have any inhibitory effect on CS-aggregation. FkpA is thus able to recognize and bind non-native protein ef®ciently. In suppressing CS-aggregation, it is as effective as the Hsp90-associated FKBP52 17 or as Hsp90 itself. 33 Besides preventing CS aggregation, FkpA can also apparently dissolve existing aggregates, as indicated by the decrease in light scattering, when FkpA is added later on, after the onset of aggregation ( Figure 5(b) ).
FkpA binds reversibly to early unfolding intermediates of CS
Different families of chaperones have been shown to bind different types of folding intermediates, and they are also distinct in their binding mode. Binding can be either weak and thus transient, as in the case of Hsp90, or strong and thus essentially permanent, hence requiring further factors for release. In order to obtain additional information about the molecular mechanism of the chaperone activity of FkpA, we have investigated its in¯uence on the CS-inactivation kinetics.
CS inactivation in the absence of chaperones occurs with an apparent rate of 0.0093 s À1 at 43 C ( Figure 5(c) ), as has been demonstrated before. 33 FkpA at 0.6 mM (eightfold molar excess) slows the inactivation-kinetics of CS by a factor of 11, with 40 % active molecules still present after an incubation period of 20 minutes at 43 C ( Figure 5(c) ). It is thus more than twice as effective as a stabilizing agent than yeast Hsp90, which yields 20 % active CS after incubation for the same period with the same molar excess of chaperone, slowing down the inactivation process by a factor of 5. 33 Upon inactivation of CS, intermediate states are populated transiently that can be reactivated by the addition of OAA, which binds to the enzyme and stabilizes the native state. In the absence of chaperones the reactivatable intermediates reach a maximum at around two minutes and then disappear within 20 minutes (Figure 5(c) ). FkpA prevents signi®cant accumulation of the reactivatable unfolding intermediates within the ®rst few minutes and instead leads to an increased persistance of the native state at this time. In the presence of FkpA, such intermediates are found at later time points than in its absence, with 10 % still present after 60 minutes of incubation at 43 C ( Figure 5(c) ). This behavior is reminiscent of Hsp90 33 and indicates that FkpA is able to interact transiently with early, native-like CS-unfolding intermediates, and release them in a productive fashion, such that they can be reactivated. Irreversible binding to FkpA, on the other hand, would not be expected to slow the inactivation kinetics, nor should reactivation be possible, and it thus does not seem to occur under these conditions.
Binding of CS-unfolding intermediates is not influenced by inhibition of isomerase activity
Preincubation of FkpA with a tenfold molar excess (6 mM) of the inhibitor FK520 only has a very marginal in¯uence, both on its ability to slow down the aggregation kinetics of CS ( Figure 5(a) ) and on its ability to dissolve preexisting aggregates ( Figure 5(a) and (b) , compare corresponding open and closed symbols). The slight increase in aggregation might even be an effect of FK520 itself on aggregation, rather than an effect due to inhibition of FkpA. This view is supported by the fact that the kinetics of loss of enzymatic activity, decelerated in the presence of FkpA, are not in¯uenced at all by the additional presence of the inhibitor ( Figure 5(c) ) even at a 100-fold excess (60 mM). At these inhibitor concentrations both active sites of the FkpA dimer are fully inhibited, and binding has been shown to occur despite the elevated temperature (Figure 3(a) and (b) ).
Obstruction of the active site therefore does not interfere with the chaperone effect of FkpA on CS under unfolding conditions. This implies that the binding of unfolding intermediates of CS to FkpA occurs at a second site, distinct from the isomerase active site and separated widely enough from it to remain undisturbed by the presence of the inhibitor. These results correlate with the inhibition data described above and support the hypothesis of a second non-speci®c polypeptide binding site, in addition to the active site. It mediates chaperone activity on the one hand, and on the other hand is responsible for the high catalytic activity with folding proteins by lowering K M .
Both activities reside primarily in the FKBP-domain
To identify the location of the additional binding activity of FkpA, we expressed the two domains constituting the monomer separately and investigated their activity. The domain boundaries were deduced from a homology model{ with the crystal structure of hFKBP12. We de®ned as the N-terminal domain residues 1 to 122 and as the FKBPdomain residues 122 to 245 of the mature wt FkpA protein.
Both domains could be expressed in soluble form in large amounts, both in the peri-and in the cytoplasm. The N-terminal, non-FKBP domain was found to be monomeric in solution, but it formed tetramers after prolonged storage at high concentrations. The C-terminal FKBP-domain showed an even more pronounced tendency to oligomerize. This was unexpected due to the high degree of homology of the FKBP-domain with other monomeric FKBPs (47 % identity with human FKBP12). Upon expression of the FKBP-domain under control of a strong promotor in the cytoplasm, formation of stable tetramers was observed in gel ®ltration, and no concentration dependence was found over the ®vefold concentration range tested (data not shown). The interactions in these tetrameric species are probably non-native, since they were devoid of any activity, i.e. isomerase or chaperone.
When the FKBP-domain was expressed under the control of a weaker promotor and exported to the periplasm, an equilibrium mixture of different oligomeric forms and the monomer (about 50 %) could be isolated. This mixture, although inactive in the RNaseT1 folding assay (see Figure 7 (a)), retained tenfold reduced isomerase activity with the tetrapeptide substrate (data not shown), compared to an equimolar concentration of the wt active site. This could, however, be an underestimate, since we do not know what percentage of the monomeric species is active. The N-terminal domain, on the other hand, showed no activity in either of the two isomerase assays. Mixing of the two domains could not reconstitute the catalytic activity with the folding protein, nor did it increase the activity of the isolated FKBP-domain towards the tetrapeptide. These ®ndings are paralleled by the inability of the two domains to form the native homodimer, as judged by gel ®ltration experiments.
The chaperone activity of the isolated domains was quanti®ed by two independent methods. On the one hand, prevention of CS aggregation at { Guido Capitani, personal communication.
Chaperone and Isomerase Activity of FkpA 43 C was measured as described above, and on the other the increase in refolding yield of the antibody scFv fragment 4D5 À À scFv was determined, as described in detail elsewhere. 15 The two minus signs describe the absence of both disul®de bonds. In both assays the isolated FKBP-domain seems to be highly active. CS aggregation is delayed considerably and reduced to a high extent by the presence of an eightfold molar excess of the FKBPdomain (Figure 6(a) ). The N-terminal domain has only a small effect on CS aggregation. A combination of both domains, only increases the effect marginally, compared to the FKBP domain alone.
Since the experiments with thermal unfolding of CS have to be carried out at elevated temperature, where the stability of the isolated domains might be affected, we additionally performed refolding experiments with the 4D5 À À scFv at 10 C, followed by ELISA quanti®cation of the refolding yield. While the N-terminal domain has no in¯u-ence on the yield of active scFv, the presence of the FKBP domain alone accounts for the entire chaperone activity of the wt FkpA in this assay (Figure 6(b) ).
Both activities, i.e. isomerase and chaperone, thus seem to be located essentially in the FKBP domain. Although the isolated FKBP domain is reduced in its catalytic cis-trans isomerase activity, it retains almost full chaperone activity. Covalent linking of the domains and correct dimerization, mediated by the N-terminal domain, on the other hand, seems to be required for full isomerase activity with protein substrates and it may also enhance chaperone activity.
As already mentioned above, these ®ndings are rather surprising considering the high degree of homology that the catalytic domain of FkpA shares with other FKBPs that are, however, monomeric and show no chaperone activity. The identity on the protein level to human FKBP12 is as high as 47 %. Even higher scores are observed with FKBP domains from other two-domain proteins, which are known to be dimeric in solution and have already been suggested to form a subfamily of FKB-proteins. 13 The closest relative (60 % identity) is the H. in¯uenzae homolog FkpY, 34 while FKBP22 from E. coli 35 has 52 % identity and the MIP-proteins from different Legionella species 36 around 48 %. The identity of the FkpA N-terminal domain is, however, never higher than 25 % with any of the MIPs or FKBP22, implying that the need for conservation in this part may be rather low.
FkpY from Haemophilus influenzae has identical characteristics
FkpY from H. in¯uenzae is the closest homolog to FkpA found in the database, with an overall identity of 46 %, with 60 % in the FKBP domain and 34 % in the N-terminal domain. FkpY is shortened with respect to FkpA, by 11 amino acid residues at the N terminus and by 16 amino acid residues at the C terminus. Interestingly, FkpA is proteolytically cleaved upon prolonged storage at both the N and the C terminus at sites close to these positions, indicating that the termini might be less well structured than the rest of the FkpA protein. Both the shortened FkpA mutant corresponding in length to FkpY, and FkpY itself have essentially the same characteristics as wt FkpA. Both proteins are exclusively dimeric in solution and their stability towards denaturant is identical with that of the wt FkpA (data not shown). Both catalyze the refolding of RNaseT1 ef®ciently, with only slight variations in activity compared to FkpA wt (Figure 7(a) ). Both proteins also display chaper- one activity. In the case of the shortened FkpA mutant, it is unchanged compared to that of the wild-type (Figure 7(b) and (c) ). FkpY, on the other hand, has a different activity pattern for the two chaperone substrates investigated. While it is less active than FkpA in the CS aggregation assay (Figure 7(b) ), its effectiveness in increasing the scFv refolding yield is higher (Figure 7(c) ). This could be due to a different amino acid composition of the hypothetical polypeptide binding site. In light of the almost identical activities in vitro, the less stringent conservation of the N-terminal domain may be indicative for a more structural function of this part, as has already been suggested above.
Discussion
From the results described above, it is clear that the high enzymatic activity of FkpA with folding proteins and its independent chaperone function have the same basis. On the one hand, a low K M value for the folding protein substrate increases the k cat /K M value for the catalyzed reaction. Reversible binding of refolding and unfolding intermediates, on the other hand, mediates the chaperone effect. In both cases, binding of the polypeptide occurs at a second, probably rather unspeci®c binding site. This polypeptide-binding site must be distinct from the active site, even through it may be adjacent, based on the fact that binding of CS unfolding intermediates is undisturbed by the presence of the active site inhibitor FK520 and, conversely, that protein binding, but not peptide catalysis can be competed for by an unfolded protein (RCM-la). Moreover, the af®nity of the peptide-binding site towards speci®c substrates seems to differ between homologous proteins, although the active site is highly conserved, and all FKBPs are known to have the same characteristic substrate speci®city with regard to tetrapeptide substrates for the active site. 37 It is, however, clear that in the case of rather unstructured substrates, especially those that are subject to both catalytic and chaperone activity, both active sites may well contribute to substrate binding, as well as to the observed chaperone effect, rendering an attempted disentangling of the contributions more dif®cult.
Surprisingly, both functions of FkpA, isomerase and chaperone, appear to be located in the FKBPdomain and may be adjacent, as both need to contribute to binding the same protein molecule. This was inferred from the observation that the isolated FKBP-domain retains the binding capacity for folding intermediates in vitro, demonstrated by the chaperone assays with unfolding CS and refolding Chaperone 27 very recently, with a deletion mutant of FkpA lacking the greater part of the N-terminal domain. The authors ®nd that the deletion mutant of FkpA has no chaperone effect on their substrate protein MalE31 upon coexpression in vivo and conclude that the chaperone activity hence requires the N-terminal domain. We observe, however, that the isolated FKBP domain shows a high tendency to oligomerize upon strong overexpression in vivo and to form stable, but inactive tetramers. This result was at ®rst unexpected but it is in accordance with recent ®ndings which suggest that dimerization involving the active sites and hence leading to inactivation may be a latent property of the FKBP fold. 38 A closer look at the homology within the subfamily of dimeric FKBPs may further support our argument for a more structural function of the N-terminal domain of these FKBPs, securing the dimerization, orientation and stability of the FKBP domain. While the homology in the FKBP domain of this subfamily is very high, not only within the active site, the homology in the additional N-terminal domain is rather low, mostly below 25 %. From these sequence comparisons, it had already been concluded that any enzymatic or binding function of these domains cannot be conserved. 35 In the example of FkpY, the identity to FkpA in the FKBP domain is 60 %, which corresponds to the average identity observed between orthologous pairs in a recent comparison of the E. coli and H. in¯uenzae genomes. 39 The percent identity of the N-terminal domain of FkpY to FkpA (34 %), on the other hand, lies below the lower limit found for the majority of the orthologs. It is therefore conceivable that the function of this additional domain is merely the formation of the correct quartenary structure, particularly to secure the relative distance and orientation of the FKBP-domains, with no requirement for binding or catalysis. The evolutionary pressure on this domain would thus be on maintaining the structure, and many sequences may ful®ll this function. The current working model for FkpA and similar dimeric FKBPs can be summarized as follows (Figure 8 ). Each FKBP domain contains an active site catalyzing proline residue cis/trans isomerization, and a separate protein binding site, which may, however, overlap with the active site. A denatured protein such as RCM-la can bind to the protein binding site, without necessarily engaging in the active site, thereby not inhibiting the PPIase activity with a short peptide substrate. Catalysis of a protein substrate is, however, severely impaired by the presence of such a denatured protein, since it competes for the additional protein binding site that is at the basis of the high catalytic activity of FkpA with protein substrates. Conversely, FK520 inhibits isomerase activity with the protein and the peptide substrate. Since the chaperone activity is mainly mediated by the additional polypetidebinding site, it is not necessarily affected by the inhibitor binding to the active sites. In cases, however, where the chaperone substrate is mostly unfolded and/or is also a substrate for isomeriza- Figure 8 . Model for the prolyl-isomerase and chaperone activities of the FkpA dimer. The protein folding and unfolding intermediates interact with a polypeptide-binding site (black), distinct from the active site (indicated as a cavity), and both are located on the FKBP-domain. Two tetrapeptides can be bound and isomerized simultaneously by the FkpA dimer, but only one protein molecule. In the chaperone activity on non-cis-proline substrates (right), binding to the active site may occur but appears to be non-essential. For more explanations see text.
tion catalysis, the interaction with the catalytic site may well contribute to the overall binding. The N-terminal domain of FkpA then has an entirely structural function, keeping the FKBP-domains in an orientation, such that a protein substrate can bind to both domains at the same time, i.e. that they face each other. While the chaperone activity can also be mediated by the isolated FKBP domain, dimerization to the correct native homodimer of the two domain protein probably enhances chaperone function through an avidity effect and it is a prerequisite for the ef®cient catalysis of protein folding. The recently solved crystal structure of the FkpA-homolog MIP from L. pneumophila (R. Hilgenfeld et al., unpublished data; ribbon structure at http://www.imb-jena.de/www_sbx/projects/ sbx_mip.html) supports such an interpretation, since it shows that the two FKBP-domains are juxtaposed in such a way that they can interact with the same substrate, the precise orientation being determined by the long, potentially¯exible helix within this N-terminal domain.
Well adapted, highly evolved enzymes usually have maximized turnover at the substrate concentrations they encounter within the cell. This requires a high turnover together with relatively weak substrate binding. By this criterion FkpA, like other FKBPs, 26 does not appear to have evolved towards the expected properties for ef®-ciently catalyzing protein substrates. Rather than by a high turnover, catalysis is enhanced through tight substrate binding, mediated by a second site. In light of the chaperone activity observed for FkpA and other FKB-proteins, this may indicate that folding catalysts, such as PPIases and disul®de isomerases, may have been subject to a twofold selective pressure, especially in such cellular compartments as the periplasm of bacteria, where no dedicated chaperone network seems to exist. More precisely, the presence of an additional highaf®nity polypeptide-binding site may provide a gratuitous advantage, apart from increasing catalytic activity, compared to a protein with high turnover and low substrate af®nity. The additional, independent chaperone function mediated by such a polypeptide-binding site could constitute an important selective advantage, especially in the periplasm of E. coli. The absence of a classical chaperone network in the periplasm and the number of periplasmic folding catalysts for which an additional, independent chaperone activity has been proposed 15,31,40 ± 42 seem to support this hypothesis. It is therefore conceivable that the subfamily of two-domain, dimeric FKBPs, among them FkpA, FkpY, and the MIP proteins, may ful®ll a twofold function in vivo that comprises proline isomerization on the one hand and, independent from this activity, chaperone function on the other.
The fact that both features seem to be located within the conserved FKBP-domain may shed a new light on the entire family of FKPBs that are generally believed to be much poorer catalysts (10 to 20-fold) than the cyclophilins. 3 At the same time, the data might facilitate understanding of the puzzling fact that hardly any of the many PPIases is essential. Yeast, for example, is viable when all of its four FKBPs and eight cyclophilins are deleted. 6 If the in vivo function of at least a subset of them consists to a high extent in the prevention of aggregation through their chaperone activity, which will be independent of proline isomerization in many cases, then it is clear that several other proteins could potentially replace them. In the periplasm of E. coli, the PPIases FkpA 15, 31 and SurA 40 and the disul®de-isomerases DsbG 42 and DsbC 41 are four examples of such proteins, for which an additional chaperone activity has been described. It thus appears that a number of proteins, whose activity involves transient binding to polypeptides, have evolved binding sites which give them a chaperone function, even independent of the original catalytic activity.
Experimental Procedures Protein expression and purification
Expression and puri®cation of the disul®de-free hu4D5-8 antibody scFv fragment (abbreviated 4D5 À À ), where the two minus signs denote the absence of both disul®de bonds and of FkpA with and without His-tag were carried out as described. 15, 43 The FkpA ORF contains a signal sequence of 25 amino acid residues, followed by the mature protein of 245 amino acid residues. The FkpA construct termed``shortened FkpA'' is missing the ®rst 9 N-terminal and 18 C-terminal amino acid residues of the mature protein. The N-terminal domain construct encompasses amino acid residues 1 to 122 of the mature wt FkpA, the construct of the C-terminal domain starts at amino acid residues 122. FkpY from a H. in¯u-enzae, 34 clone obtained from the TIGR/ATCC was also investigated. All four sequences were cloned without signal sequence into the vector pTFT74 with C-terminal His-tag, 44 which places them under the control of the phage T7-promotor for cytoplasmic expression. Expression was carried out at 25 C in E. coli BL21 with induction by IPTG overnight. The domains were additionally subcloned into the vector pAK400 45 for periplasmic expression with the pelB signal sequence, and expressed under control of the lac promotor at 25 C. For puri®cation, the soluble cell extracts were passed over an immobilized metal ion af®nity chromatography (IMAC) column at pH 7, followed by S/H-cation exchange chromatography at pH 6 for the FkpA mutant, FkpY and the FKBP domain, while for the N-terminal both columns were run at pH 7.5. Protein concentrations were determined using absorption coef®cients. 46 FkpA and FkpY concentrations given refer to the molar concentrations of dimers.
Yeast citrate synthase was a kind gift from Dr Peter Lindner, puri®ed as described. 47 Human FKBP12 was a kind gift from Dr Heinz Gehring, FK520 was a gift from Novartis (Basel), and the antigen HER2 extracellular domain was a gift from Genentech (South San Francisco). The S54G/P55N-variant of RNaseT1 from Aspergillus oryzae was a gift from Raimund Maier and Professor Franz X. Schmid (University of Bayreath). Its reduction and carboxymethylation was carried out as described. 28 Wild-type RNaseT1 from Aspergillus oryzae and the carChaperone and Isomerase Activity of FkpA boxymethylated bovine a-lactalbumin were both obtained from Sigma.
Analytical gel filtration
Analytical gel ®ltration experiments were carried out on a SMART system with a Superose-12 column in 50 mM Tris (pH 7.0), 150 mM NaCl, 0.005 % Tween-20.
Fluorescence titration
Fluorescence measurements were performed with a PTI Alpha Scan spectro¯uorimeter (Photon Technologies Inc.) at 25 and 38 C, as indicated, using excitation and emission wavelengths of 280 nm and 307 nm, respectively. The buffer was 50 mM Tris (pH 7.0), 50 mM NaCl (®ltered, degassed). FkpA at 1 mM (dimer) was incubated with increasing amounts of the inhibitor FK520 before measurements were taken, and the obtained¯uorescence signal was corrected for the¯uorescence of the buffer and the dilution effect. Before measurements were started, the protein solution was preincubated in the cuvette to minimize artefacts due to¯uorescence decrease caused by absorption of FkpA to the cuvettewalls during the titration experiments. The binding curve obtained was analyzed using Kaleidagraph (Synergy Software, Reading, UK) by ®tting to a quadratic equation, as described, 48 assuming two identical binding sites.
RNaseT1-refolding assay
The refolding assays with the wild-type (wt) RNaseT1 were carried out essentially as described. 15 In experiments with the carboxymethylated S54G/P55N-variant (RCM-RNaseT1), the protein was unfolded in 100 mM Tris (pH 8) and the refolding buffer contained additionally 2 M NaCl for stability. The salt concentration had no effect on the catalytic activity of FkpA. The ®nal FkpAdimer concentration was either 5 or 10 nM, as indicated. For the determination of Michaelis-Menten parameters, the RNaseT1 concentration was varied from 0.05 to 2 mM (wt) or 6 mM (RCM-RNaseT1). The kinetic traces obtained were analyzed by global ®tting with numeric iteration using the software DynaFit 21 in a model that accounted for the presence of the uncatalyzed reaction, described by the following reaction mechanism:
K M is treated as an equilibrium constant, k cat and k 0 are ®rst-order rate constants and k 0 is the rate of the uncatalyzed folding reaction. The subscripts U and N refer to the unfolded and native state, respectively. Fit parameters were K M and k cat , while the uncatalyzed rate was determined separately and held constant, and folding reactions were considered to be irreversible under the conditions used. The ®nal concentration used in the inhibition measurements was 0.4 mM wt RNaseT1. Kinetic traces were evaluated with double exponential functions using Kaleidagraph and the rates of the faster phases were plotted against the inhibitor concentration. Control experiments (data not shown) showed that neither FK520 nor RCM-la had by themselves any effect on the rate or the yield of RNaseT1 refolding under the conditions used.
Protease-free assay for peptidyl prolyl isomerization
The improved assay conditions introduced by Kofron et al. 49 were used in an assay carried out in the absence of protease, as described initially by Janowski et al. 19 The tetrapeptide had the sequence succinyl-Ala-Ala-Pro-Phenitroanilide and was used at a ®nal concentration of 120 mM. Measurements were carried out at 10 C in plastic cuvettes, and the decrease in absorbance was followed at 330 nm for six minutes. Kinetic traces were analyzed by a non-linear least-squares ®t to a single exponential function using Kaleidagraph, and an initial estimate for k cat /K M was obtained from the slope of a plot of the rate versus the enzyme concentration used. Human FKBP12 was used as a control.
Citrate synthase aggregation
Citrate synthase (CS) aggregation was followed by light scattering measurements with a PTI Alpha Scan spectro¯uorimeter (Photon Technologies Inc.) at 43 C, using an excitation and emission wavelength of 500 nm. The ®nal CS concentration was 0.075 mM in 35 mM Hepes (pH 7.8) (®ltered, degassed). Concentrations of FkpA, either present from the start or added later on, were as indicated.
Citrate synthase inactivation
CS at a concentration of 0.075 mM in 35 mM Hepes (pH 7.8) was incubated at 43 C, alone or in the presence of FkpA and FK520, as indicated. Inactivation and reactivation were followed by measuring activity at the respective time points. Activity measurements were carried out at 25 C in an assay containing 200 mM oxaloacetate (OAA), 100 mM DNTB and 100 mM acetyl-CoA in 200 mM Tris (pH 8), freshly mixed before each measurement. Measurements were carried out in plastic cuvettes by following the increase of absorbance at 412 nm, and the activity was determined from the linear part of the progress curve, in relation to the activity of native CS, which was set to 100 %. The enzymatic reaction was started by the addition of 50 ml of CS, which had been incubated at 43 C for a given period of time, to a total volume of 1 ml. At the same time point a second aliquot of 43 C incubated CS was taken, but its reactivation was initiated by the addition of OAA to a ®nal concentration of 1 mM. The activity of the reactivated samples was measured as described above, following incubation at 25 C for one hour. The amount of reactivatable intermediate present after incubation at 43 C for a given period of time was determined from the difference of the activity with and without reactivation.
ELISA
ELISA experiments to determine the refolding yield of the 4D5 À À scFv antibody fragment were carried out as described. 15 Brie¯y, the scFv was refolded overnight from 3 M GdmCl at 10 C in the presence of chaperones as indicated and the activity was quanti®ed by ELISA. For the ELISA, plates were coated with the antigen, the HER2 extracellular domain. The refolded scFv bound to the plate was quanti®ed by an anti-myc-tag IgG from mouse, followed by a goat-anti-mouse-IgG-POD for detection. The results are averages of at least duplicate measurements that have been reproduced at least twice in independent experiments.
